Aim: The purpose of this study is to compare and correlate US evaluation with clinical scores of the disease activity in patients with rheumatoid arthritis (RA) and concomitant fibromyalgia (FM). Material and methods: Ten patients diagnosed with RA according to the 2010 ACR/EULAR classification criteria and associated FM based on the ACR 1990 classification criteria and two control groups, one with RA (10 patients) and one with FM (10 patients), were included. Clinical assessment was performed and the disease activity scores were calculated. Synovial/tenosynovial hypertrophy, fluid collections in grey scale (GS), and Power Doppler (PD) US assessed by US in the 28 joints included in the disease activity score 28 (DAS28). Results: GS US score and PD US scores were correlated with DAS28 only in patients with RA (Pearson r coefficients 0.3 and 0.5). Mean DAS28 score was significantly higher in the RA/FM group, compared to RA and FM (5.6 versus 4.6 versus 4.5, respectively). Patients with RA/FM had similar median US scores to RA patients, while in FM group significantly lower median US scores were detected (16 versus 9.5 versus 0 for GS US and 3.5 versus 1.5 versus 0 for PD US, respectively). Conclusions: Disease activity scores should be interpreted with caution in patients with RA and FM. When available, US should be used to guide treatment decisions in patients with RA and FM.
Introduction
Rheumatoid arthritis (RA) is a chronic disease characterized by synovial hypertrophy and joint destruction. In order to prevent destructive changes and maintain remission or low disease activity, a treatment algorithm based on the disease activity scores was recommended by an international task force [1] . The recommended disease activity scores are Disease Activity Score 28 (DAS28), Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) [2] . These scores include tender joint count (TJC) and swollen joint count (SJC), patient global assessment (PGA), physician global assessment (PhGA) and erythrocyte sedimentation rate (ESR) [2] .
Fibromyalgia (FM), a chronic disease characterized by diffuse pain, sleep disturbances and somatic symptoms, is present in 17% of patients with RA [3] . RA patients with associated FM have higher disability index, lower quality of life, and higher medical costs [3] . It seems that an even higher percent of patients with RA may present features of FM and increased pain sensitivity without satisfying diagnostic criteria for FM. These patients have higher patient reported components of the disease activity scores [4] . Wolfe et al evaluated the effect of polysymptomatic distress, a composite measure of fibromyalgianess derived from the 2010 classification criteria for FM, on disease activity measurements in patients with RA [5] . Polysymptomatic distress influenced disease activity scores and authors concluded that these scores cannot discriminate between active disease and patient distress [5] . When DAS28 score was applied to patients with FM it did not differ significantly from the scores obtained for patients with RA. This raised the hypothesis that applying these scores in patients with RA and associated FM would cause an overestimation of disease activity [6] . In a prospective study, FM coexistence was an independent predictor of higher DAS28 score in patients with RA [7] . Ultrasonography (US) is an important tool for detecting synovitis, complementary to clinical examination [8] . Synovial hypertrophy and effusions are examined by using gray scale (GS) ultrasound and the neovascularisation within the synovitis is detected by using the Power Doppler (PD) US [8] .
US has also been proven to predict RA radiological progression at the joint level and is a good marker of prognosis [9] . US scores have been developed and tested, with different number of joints examined and several scoring systems regarding GS and PD examination [10] . The most widely used scoring system for small joints and tenosynovitis is the one proposed by Backhaus et al [11] . The Sonography of Large Joints in Rheumatology (SOLAR) is the only validated score that evaluates semiquantitatively GS and PD in large joints [12] .
The main aim of this study is to evaluate and to compare the US (in GS and PD) and DAS28 scores between RA, RA and associated FM and FM patients. Our secondary aim is to correlate the US scores with clinical disease activity in the aforementioned patient groups.
Material and methods
This cross-sectional case-control study was performed in the Rheumatology Clinic, Emergency Clinical County Hospital Cluj-Napoca between November 2014 and March 2015. Adult female patients who fulfilled 2010 ACR/EULAR classification criteria for RA [13] and 1990 classification criteria for FM [14] were consecutively enrolled from the outpatient clinic by their attending physicians (LOD, LMM, and IF). Two agematched control groups were included, one with RA and one with FM. Exclusion criteria consisted of any other concomitant inflammatory disease, infection, pregnancy, and lactation. The study was conducted according to the Declaration of Helsinki and the protocol was approved by "Iuliu Haţieganu" University of Medicine and Pharmacy Ethics Committee. All subjects signed a written informed consent.
Clinical scores for the disease activity and US scores were performed at 28 joints included in DAS28. Performance of US versus clinical assessment in patients with RA and concomitant FM and in the control groups was assessed.
US was performed by the same experienced ultrasonographer (MMT) (>5 years experience). Both the clinician and the ultrasonographer were blinded to the patient's diagnosis.
Clinical assessment
All patients underwent evaluation of 28 joints: 1-5 metacarpophalangeal (MCP), 1-5 proximal interphalangeal (PIP), wrist, elbow, shoulder, knee bilaterally. TJC, SJC, PGA, PhGA, number of tender points for fibromyalgia (NTP) were recorded by one of the investigators (LJG). ESR was measured at 1 hour (normal< 20mm/h). Additional data was retrieved from patients charts regarding duration of disease, IG M rheumatoid factor (RF) positivity (RF, normal > 32 UI/ml) and anti-cyclic citrullinated peptide antibody positivity (aCCP, normal >5 UI/ml), current treatment. All patients completed health assessment questionnaire -disability index (HAQ-DI). DAS28 was calculated with ESR value. Values lower or equal to 2.6 were interpreted as remission, between 2.6 and 3.2 as low disease activity, between 3.2 and 5.1 as moderate disease activity, and ≥5.1as high disease activity. For CDAI remission was considered between 0-2.8, low disease activity 2.9-10, moderate disease activity 10.1-22 and high disease activity 22.1-76 [15, 16] .
Ultrasound examination
Ultrasound was performed by on Acuson S2000 (Siemens Healthcare), equipped with high frequency linear probes (18 MHz). PD settings were optimized to low wall filters, a pulse repetition frequency of 900 Hz and the color gain was set below noise floor. Twenty eight joints included in DAS28 were examined. Synovial hypertrophy, tenosynovitis and fluid collections were assessed according to musculoskeletal ultrasound guidelines [11] . Wrists and MCP joints were examined in the longitudinal plane, from the dorsal aspect and PIP joints from the volar aspect to assess the presence of synovial fluid/ hypertrophy (GS) and synovial vascularisation (PD) (1 scan each joint). Compartment 6 of the dorsal wrist (extensor ulnari carpis tendon) and 1-5 finger flexor tendons were scanned for the detection of tenosynovitis (TS) in GS and PD US [17] in both hands. A total of 12 tendons were scanned for the detection of TS. Large joints were scanned according to the SOLAR score: shoulder -glenohumeral posterior transverse, axillary longitudinal (2 scans), elbow -humeroradial, humeroulnar, olecranon fossa (3 scans), knee -suprapatellar longitudinal, medial, and lateral femurotibial, dorsal longitudinal (4 scans) [12] . A total of 42 scans/ patient at joints level were obtained.
Semi-quantitative GS and PD scores (grade 0-3) were used for small joints [11] , for large joints [12] , and qualitative scores for GS TS (0-absent, 1-present) and semiquantitative (0-3) for PD TS [17] . A total score of (0-3) x 42 for GS and for PD, respectively and 0-12 for GS TS and (0-3) x 12 for PD TS, was calculated for each patient.
Statistical analysis
Statistical analysis was performed with SPSS v20. Normal distributions were checked with histograms and Shapiro Wilk test. Data are represented as mean (SD) if normally distributed or median (IQR) for non normal distributions. Differences between groups were tested with One Way Anova for normally distributed data or Kruskal Wallis test for non-normally distributed data. Post hoc analysis was performed using Mann U Whitney test for each pair of groups with adjusted the p value using the Bonferroni multiple comparison procedure (p<0.016). Testing for homogeneity of variance was performed with the Levene test. Correlations were calculated by using Pearson correlation coefficient. A significance value of p<0.05 was used.
Results
Thirty female patients (10 with RA, 10 with RA and FM, and 10 with FM) were included and 840 joints were examined by US. Demographics, clinical data, and medication use in patients and disease controls are shown in Table I .
Clinical assessment TJC and PGA were higher in the RA/FM group comparing to RA and FM, respectively. SJC and ESR were not significantly different between the RA and RA/FM group, but significantly lower in the FM group (Table II) . Values are expressed as mean (%) or median (25,75 percentiles); *Differences significant for RA group;**Differences significant for RA/FM group;***Differences significant for FM group; ¶ No significant differences at post-hoc analysis; TJC-tender joint count, SJC-swollen joint count, PGH on VAS-patients global health on visual analogue scale (0-100), DAS28-disease activity score with 28 joints; CDAI-clinical disease activity; US GS score-ultrasonography gray scale score; US PD score-ultrasonography Power Doppler score; HAQ-health assessment questionnaire
Patients with RA/FM had higher DAS28 scores, eight out of ten patients being classified as having high disease activity. By contrast, only 4 out of 10 RA presented DAS28 scores corresponding to high disease activity (fig 1) .
Ultrasound scores GS US score ranged from 0 to 36 in the RA group, from 0 to24 in the RA/FM group, and from 0 to 11 in the FM group. PD scores varied from 0 to 24 in the RA group, from 0 to 11 in the RA/FM group and from 0 to 2 in the FM group. Median GS and PD US scores were significantly different between the 3 groups (Table II) . At post hoc analysis significant differences were found between the FM and RA groups for PD US (p= 0.014), but not for GS US (p= 0.04). The same results were obtained when we compared median US scores between the RA / FM group and FM group: p=0.06 for GS US and p=0.003 for PD US. No significant differences were noted between US scores in the RA and RA/FM groups (p=0.2 for GS US and p=0.6 for PD US).
US scores correlated moderately only with DAS28 and CDAI in patients with RA, and not in patients with RA/FM. These scores were inversely correlated with DAS28 and CDAI in FM patients (Table III) .
TS GS scores had minimum and maximum values from 0 to 6 for the RA group, 0 to 4 in the RA/FM group, and 0 to 2 in the FM group. TS PD scores ranged between minimum and maximum values of 0 to 6 for RA, 0 to 2 for RA/FM, and 0 to 1 for FM.
Discussions
Our results showed that DAS28 is not a reliable measure of disease activity in patients with RA and associated FM, due to the higher TJC and PGH. US examination can assess more objectively the disease activity by evaluating the presence of the joint synovitis and tenosynovitis, especially in the presence of PD signal in these patients.
These findings are similar to those of previous studies. Ranzolin et al found that patients with RA and associated FM had higher disease activity scores, disability, and worse quality of life compared to those with RA alone [7] . Another study found that US synovitis score in 7 joints (US 7) was a better tool of assessing disease activity than composite disease activity scores in patients with RA and associated FM. The PD US7 score correlated with DAS28 only in patients without FM [17] . Our findings show small correlation coefficients between GS US and DAS28 and moderate for PD US and DAS28, suggesting that PD US could perform better in assessing disease activity in patients with RA and associated FM.
In our study, although ESR and SJC values were similar between the RA and RA/FM group, DAS 28 (ESR) and CDAI values were significantly higher in the RA/FM group, pointing out as previously found in other studies [6, 18] , to higher TJC and PGA in patients with associated FM. TJC was significantly lower in patients with RA compared to those with RA/ FM and FM probably due to central sensitivity mechanisms of pain and not to inflammation [3] .
PD US was demonstrated to be a sensitive method for assessment of the clinical activity in RA patients [19] and PD activity was comparable to that of magnetic resonance imaging [20] . In our study, PD US scores were similar between the RA and RA/FM group, although DAS 28 scores were higher in the RA/FM group. GS scores were significantly different between the 3 groups of patients, but pair wise comparisons did not reach levels of statistical significance, probably due to the small number of subjects.
Another core measurement in RA is the HAQ-DI [21] . RA patients have a higher disability index that the normal population [22] and patients with RA/FM exhibit higher HAQ scores than those with FM [7] . In our study, patients with RA/FM had the highest HAQ score, but values did not reach a statistical significance. Longer RA duration in the RA/FM group could also explain the higher disability index in this group. When employing treat to target or tight control treatment regimens for RA, FM status should be assessed and decisions should be taken carefully, considering objective individual components of DAS28 such as SJC or ESR/ CRP. Another option would be to take treatment decisions based on US findings.
In many countries reimbursement of biological treatment and monitoring during treatment is based on DAS28 scores [23] . Patients should not be labeled as non responders to biological therapy only based on the DAS28 score, but also based on US examination if available. A recent study by Kay et al found that a significant proportion of patients in the United States RA registry have clinically active disease despite normal values of ESR and CRP [24] . Another study found that ESR and CRP are weakly correlated between each other and with disease activity in RA [25] . Thus, acute phase reactants like ESR and CRP cannot be used to distinguish between active and inactive disease in all patients with RA and associated FM.
To our knowledge this is the first study that directly compared 28 joints ultrasound score of patients with RA, RA/FM and FM.
One of the limitations of our study is the small number of patients included. We did not use the SDAI because CRP was not available for all patients. In a recent review by Gaujoux-Viala et al the DAS 28, CDAI, and SDAI were shown to perform similarly concerning sensitivity to change, intraobserver reproductibility, concordance, construct validity and performance [26] . We chose to use dorsal scans for MCP joints based on findings of Szkudlarek et al that showed a higher percent of dorsal compared to palmar US involvement in RA [27] . Other studies showed a preponderance of palmar involvement in MCP joints of patients with RA [28] . Both sides should probably be scanned in order not to miss involved joints and we acknowledge this as another limitation of our study.
Recent studies suggest that central mechanisms of pain play an important role in rheumatoid arthritis and patients exhibit features of fibromyalgia [4, 5] . In this context US assessment of disease activity in the presence of low pain thresholds should be studied.
Conclusions
Patients with RA and associated FM have similar US scores with RA patients, but higher disease activity scores due to increased TJC and reported PGA. Only PD US significantly differ in patients with RA versus FM. DAS 28 was correlated with PD US only in RA and not in RA/FM or FM patients. In order to assess disease activity objectively disease activity scores should be interpreted with caution and when available US should be used to guide treatment decisions in patients with RA and FM.
